Clinical Trials Browser

Phase 1 × Cholangitis, Sclerosing × Erlotinib Hydrochloride × Clear all

NCT00955149 2014-01-10

Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)

Phase 1 Completed

Gastrointestinal

Cholangitis, Sclerosing, Cholangiocarcinoma